- ¥2980
- LMAI Bio
- LM-1850R-FITC
- 中国/美国/欧洲
- 2025年07月12日
- Flow-Cyt=1:50-200 IF=1:50-200
- Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit,
- Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit,
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
上海联迈生物工程有限公司
- 库存：
大量
- 靶点：
详见说明书
- 级别：
1
- 目录编号：
LM-1850R-FITC
- 克隆性：
多克隆
- 抗原来源：
Rabbit
- 保质期：
1年
- 抗体英文名：
Anti-NR3C2/Mineralocorticoid receptor/FITC
- 抗体名：
Anti-NR3C2/Mineralocorticoid receptor/FITC
- 标记物：
FITC标记
- 宿主：
Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit,
- 适应物种：
Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit,
- 免疫原：
详见说明书
- 亚型：
IGg
- 形态：
粉末、液体、冻干粉
- 应用范围：
Flow-Cyt=1:50-200 IF=1:50-200
- 浓度：
1mg/ml
- 保存条件：
-20 °C
- 规格：
100ul
| 英文名称 | Anti-NR3C2/Mineralocorticoid receptor/FITC |
| 中文名称 | FITC标记的盐皮质激素受体抗体 |
| 别 名 | Aldosterone receptor; MCR; MGC133092; MLR; MR; NR3 C2; NR3C2; NR3C2 protein; Nuclear receptor subfamily 3 group C member 2; MCR_HUMAN. |
| 规格价格 | 100ul/2980元 购买 大包装/询价 |
| 说 明 书 | 100ul |
| 研究领域 | 细胞生物 免疫学 转录调节因子 |
| 抗体来源 | Rabbit |
| 克隆类型 | Polyclonal |
| 交叉反应 | Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit, |
| 产品应用 | Flow-Cyt=1:50-200 IF=1:50-200 not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 107kDa |
| 细胞定位 | 细胞膜 |
| 性 状 | Lyophilized or Liquid |
| 浓 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human Mineralocorticoid receptor |
| 亚 型 | IgG |
| 纯化方法 | affinity purified by Protein A |
| 储 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| 保存条件 | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. |
| 产品介绍 | background: Steroid receptors are ligand dependent, intracellular proteins that stimulate transcription of specific genes by binding to specific DNA sequences following activation by the appropriate hormone. Mineralocorticoids are a family of steroids, secreted by the adrenal cortex, necessary for the regulation of a number of metabolic processes including electrolyte regulation. These compounds exert their effect through their interaction with the mineralocorticoid receptor and that complex's subsequent association with DNA. Given the function of mineralocorticoids, it is not surprising to find that the kidney is a primary target organ for mineralocorticoids and that this organ has been shown to contain Mineralocorticoid Receptor. Function: Receptor for both mineralocorticoids (MC) such as aldosterone and glucocorticoids (GC) such as corticosterone or cortisol. Binds to mineralocorticoid response elements (MRE) and transactivates target genes. The effect of MC is to increase ion and water transport and thus raise extracellular fluid volume and blood pressure and lower potassium levels. Subunit: Heteromultimeric cytoplasmic complex with HSP90, HSP70, and FKBP4, in the absence of ligand. After ligand binding, it translocates to the nucleus and binds to DNA as a homodimer and as a heterodimer with NR3C1. May interact with HSD11B2 in the absence of ligand. Binds the coactivators NCOA1, NCOA2, TIF1 and NRIP1. Subcellular Location: Cytoplasm. Nucleus. Endoplasmic reticulum membrane; Peripheral membrane protein. Note=Cytoplasmic and nuclear in the absence of ligand; nuclear after ligand-binding. When bound to HSD11B2, it is found associated with the endoplasmic reticulum membrane. Tissue Specificity: Ubiquitous. Highly expressed in distal tubules, convoluted tubules and cortical collecting duct in kidney, and in sweat glands. Detected at lower levels in cardiomyocytes, in epidermis and in colon enterocytes. Post-translational modifications: Phosphorylated. DISEASE: Defects in NR3C2 are a cause of autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735]. PHA1 is characterized by urinary salt wasting, resulting from target organ unresponsiveness to mineralocorticoids. There are 2 forms of PHA1: the autosomal dominant form that is mild, and the recessive form which is more severe and due to defects in any of the epithelial sodium channel subunits. In AD-PHA1 the target organ defect is confined to kidney. Clinical expression can vary from asymptomatic to moderate. It may be severe at birth, but symptoms remit with age. Familial and sporadic cases have been reported. Defects in NR3C2 are a cause of early-onset hypertension with severe exacerbation in pregnancy (EOHSEP) [MIM:605115]. Inheritance is autosomal dominant. The disease is characterized by the onset of severe hypertension before the age of 20, and by suppression of aldosterone secretion. Similarity: Belongs to the nuclear hormone receptor family. NR3 subfamily. Contains 1 nuclear receptor DNA-binding domain. Database links: Entrez Gene: 4306 Human Entrez Gene: 110784 Mouse Entrez Gene: 25672 Rat Omim: 600983 Human SwissProt: P08235 Human SwissProt: Q8VII8 Mouse SwissProt: P22199 Rat Unigene: 163924 Human Unigene: 723668 Human Unigene: 324393 Mouse Unigene: 9678 Rat Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. Mineralocorticoid receptor属于类固醇/甲状腺/维生素A配体依赖的转录因子受体超家族，是调节机体水盐代谢的重要甾体激素，有重要的生理、病理功能。 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验min。②荧光素的准备 根据欲标记的蛋白质总量，按每毫克免疫球蛋白加0．01mg荧光色素，用分析天平准确称取所需的异硫氰酸荧光素粉末。也可用下述公式计算出免疫球蛋白、荧光素的量，还可以算出需加缓冲液的量。a．蛋白溶液：含量Amg／m1；容积Bml。b．总蛋白量(AXB)＝Crag。c．C／20～C／10＝Dmg(如蛋白含量低于20mg／ml，用C／10；如高于20mg／ml，用C／20)。d．荧光素FITC的量：(1／50～2／100)XC＝Emg。e．巳0．5mol／L(pH9．5)碳酸盐缓冲
光波长为550nm，最大发射光波长为620nm，呈橙红色荧光。与FITC的翠绿色荧光对比鲜明，可配合用于双重标记或对比染色。其异硫氰基可与蛋白质结合，但荧光效率较低。 （2）其他荧光物质 1）酶作用后产生荧光的物质某些化合物本身无荧光效应，一旦经酶作用便形成具有强荧光的物质。例如4-甲基伞酮-β-D半乳糖苷受β-半乳糖苷酶的作用分解成4-甲基伞酮，后者可发出荧光，激发光波长为360nm，发射光波长为450nm。其他如碱性酸酶的底物4-甲基伞酮磷酸盐和辣根过氧化物酶的底物对羟基苯乙酸等。
TFAR19（PDCD5）是由本研究室在国际上首先报导的一个拥有自己知识产权的人类新基因，前期的功能研究表明，它是促进细胞凋亡的增强剂。利用荧光素（FITC）标记的TFAR19单克隆抗体为探针，对细胞凋亡过程中TFAR19蛋白的表达水平及定位研究发现，凋亡早期TFAR19表达水平增高并出现快速核转位现象，伴随着细胞核形态学的变化，持续较长时间，在凋亡小体中仍然可见。同时我们发现，凋亡早期TFAR19蛋白的核转位早于磷脂酰丝氨酸（PS）外翻和细胞核DNA的片段化，提示TFAR19蛋白的核转
技术资料暂无技术资料 索取技术资料
